Order Article Reprints

Sollima A, Rossini F, Lanza P, Pallotto C, Meschiari M, Gentile I, Stellini R, Lenzi A, Mulé A, Castagna F, et al. Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art. Antibiotics. 2024; 13(5):453. https://doi.org/10.3390/antibiotics13050453

Sollima, Alessio, Francesco Rossini, Paola Lanza, Carlo Pallotto, Marianna Meschiari, Ivan Gentile, Roberto Stellini, Angelica Lenzi, Alice Mulé, Francesca Castagna, and et al. 2024. "Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art" Antibiotics 13, no. 5: 453. https://doi.org/10.3390/antibiotics13050453

Sollima, A., Rossini, F., Lanza, P., Pallotto, C., Meschiari, M., Gentile, I., Stellini, R., Lenzi, A., Mulé, A., Castagna, F., Lorenzotti, S., Amadasi, S., Van Hauwermeiren, E., Saccani, B., Fumarola, B., Signorini, L., Castelli, F., & Matteelli, A. (2024). Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art. Antibiotics, 13(5), 453. https://doi.org/10.3390/antibiotics13050453